Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
Eberechukwu Onukwugha, PhD, MS
Advertisement
Articles by Eberechukwu Onukwugha, PhD, MS
Advertisement
Latest Updated Articles
- Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin
Published: December 13th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updated Hypertension Guidelines Are Here
2
FDA Approves Reformulated Ranitidine After 5-Year Absence
3
Application of the Age-Friendly 4M’s Movement Across Different Areas of Pharmacy
4
Carefully Consider Ethical Implications of Artificial Intelligence Use in Pharmacy
5
